Jamjoom Pharma’s profits surge 30% in 2025; dividends for H2 unveiled
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded 30.10% year-on-year (YoY) higher net profits attributable to the shareholders at SAR 463.80 million in 2025, compared with SAR 356.50 million. The earnings per …